- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03960476
Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults
March 12, 2024 updated by: Lee Lindquist, Northwestern University
This study seeks to better understand how older adult aging-in-place/long term care decision making and implementation is impacted by age-related changes (e.g.
cognition, health literacy, chronic conditions), social influences (e.g.
caregivers/supporters), and environmental factors.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Subjects who are part of the National Institute on Aging (NIA)-funded LitCog study will be given access to PlanYourLifespan.org, a web-based decision-making and planning tool.
Participants will be followed for up to 42 months to examine the mediating/moderating factors involved in decision-making, timing of decision implementation, and goal concordance.
Findings have the potential to inform healthcare providers, caregivers, health/long term care insurers, area agencies on aging, and older adults nationally in supporting aging-in-place decisions and services use.
Study Type
Interventional
Enrollment (Actual)
293
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current participant in the LitCog Trial [R01AG03611]
- English-speaking
- Community-dwelling
- Currently use a computer or tablet with internet
Exclusion Criteria:
- Previous participation in the Advanced Planning for Home Services study [IH-12-11-4259]
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Access to Web-Based Intervention
All study participants will be given access to the web-based study intervention, PlanYourLifespan.org.
|
The study intervention is a web-based planning tool, PlanYourLifespan.org
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in long-term care plan decision-making
Time Frame: Change from baseline decision-making at 36 months. Will also be measured every six months, up to 42 months.
|
Change in participant's long-term care plan decision-making from baseline to 36 months post-baseline.
Decision-making will be measured as a binary ('yes', 'no') outcome at each time-point.
|
Change from baseline decision-making at 36 months. Will also be measured every six months, up to 42 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant utilization of long-term care services
Time Frame: Baseline and every six months, up to 42 months
|
Participant utilization of long-term care services such as in-home caregivers as measured by the Resource Use Inventory (Sano M, Zhu CW, Whitehouse PJ, et al.
ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.
Alzheimer Dis Assoc Disord.
2006;20(4 Suppl 3):S191-S202.
doi:10.1097/01.wad.0000213875.63171.87).
|
Baseline and every six months, up to 42 months
|
Number of participants that implement any of their long-term care plans
Time Frame: Baseline and every six months, up to 42 months
|
The number of participants that implement any long-term care plans they have set.
This will be measured as a binary ('yes', 'no') outcome at each time-point.
|
Baseline and every six months, up to 42 months
|
Participant long-term care goal concordance
Time Frame: Baseline and every six months, up to 42 months
|
Assess whether participant's long-term care plans are carried out in accordance to their goals.
This will be measured as a binary ('yes', 'no') outcome at each time-point.
|
Baseline and every six months, up to 42 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 13, 2020
Primary Completion (Estimated)
November 29, 2024
Study Completion (Estimated)
February 28, 2025
Study Registration Dates
First Submitted
May 16, 2019
First Submitted That Met QC Criteria
May 20, 2019
First Posted (Actual)
May 23, 2019
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AG058777 (U.S. NIH Grant/Contract)
- 1R01AG058777-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeRecruitingAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.RecruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Capital Medical UniversityPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruitingAlzheimer Disease | Familial Alzheimer Disease (FAD)China
-
University of PennsylvaniaNational Institute on Aging (NIA)CompletedDementia | Alzheimer Disease, At Risk | Alzheimer Disease, Protection AgainstUnited States
-
Kyoto UniversityOsaka University; Mie University; Tokushima University; Tokyo Metropolitan Geriatric... and other collaboratorsCompletedFamilial Alzheimer Disease (FAD) | PSEN1 MutationJapan
-
University of ArizonaNational Institute on Aging (NIA); University of Southern California; Syneos... and other collaboratorsRecruitingNeurodegenerative Diseases | Alzheimer Dementia | Late Onset Alzheimer DiseaseUnited States
-
National Taiwan Normal UniversityCompletedAlzheimer Disease 2 Due to Apoe4 IsoformTaiwan
-
Northwell HealthRecruitingAlzheimer Disease | Alzheimer Disease With Delusions | Alzheimer Disease With PsychosisUnited States
-
University of Kansas Medical CenterNational Institute on Aging (NIA)CompletedHealthy Aging | Alzheimer Disease 2 Due to Apoe4 IsoformUnited States